Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Materials (Basel, Switzerland)|January 8, 2020
Effects of the γ″-Ni<sub>3</sub>Nb Phase on Mechanical Properties of Inconel 718 Superalloys with Different Heat TreatmentsLi-Shi-Bao Ling, Zheng Yin, Zhi Hu, et al.Cancer|May 27, 2021
Apatinib for the treatment of metastatic or locoregionally recurrent nasopharyngeal carcinoma after failure of chemotherapy: A multicenter, single-arm, prospective phase 2 studyXiaolan Ruan, Jin-Hui Liang, Yufei Pan, et al.Nature Communications|August 5, 2020
An optimal posttreatment surveillance strategy for cancer survivors based on an individualized risk-based approachGuan-Qun Zhou, Chen-Fei Wu, Bin Deng, et al.Ebiomedicine|April 1, 2019
Pretreatment MRI radiomics analysis allows for reliable prediction of local recurrence in non-metastatic T4 nasopharyngeal carcinomaLu-Lu Zhang, Meng-Yao Huang, Yan Li, et al.Therapeutic Advances in Medical Oncology|November 1, 2021
Development of a risk classification system combining TN-categories and circulating EBV DNA for non-metastatic NPC in 10,149 endemic casesFo-Ping Chen, Li Lin, Jin-Hui Liang, et al.JAMA|August 23, 2022
Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical TrialLing-Long Tang, Rui Guo, Ning Zhang, et al.BMJ (Clinical Research Ed.)|February 10, 2026
Standard chemoradiotherapy with concurrent and adjuvant camrelizumab in patients with high risk nasopharyngeal carcinoma: multicentre, randomised, open label, phase 3 trialRui You, Gui-Qiong Xu, Xi Ding, et al.Nature|March 12, 2026
Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinomaJiawei Lv, Dan-Xue Zheng, Jin-Hui Liang, et al.Pageof 1